Hybrid artificial liver using hepatocyte organoid culture

被引:76
作者
Funatsu, K
Ijima, H
Nakazawa, K
Yamashita, Y
Shimada, M
Sugimachi, K
机构
[1] Kyushu Univ, Fac Engn, Dept Chem Engn, Higashi Ku, Fukuoka 8128581, Japan
[2] Kyushu Univ, Fac Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128581, Japan
关键词
hybrid artificial liver support system; polyurethane foam; spheroid; hollow fiber; hepatocyte organoid; preclinical experiment;
D O I
10.1046/j.1525-1594.2001.025003194.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We developed 2 types of hybrid artificial liver modules using hepatocyte organoid culture. One was a polyurethane foam (PUF)/hepatocyte spheroid packed-bed module. Hepatocytes spontaneously formed spheroids in the PUF pores, and they maintained liver-specific functions well for at least 2 weeks in vitro. As a preclinical experiment, a hybrid artificial liver with 200 g porcine hepatocytes was applied to a pig (25 kg) with liver failure and showed that the hybrid artificial liver was effective in support of Liver functions and stabilization of general conditions. We established a new technique of hepatocyte organoid formation using centrifugal force. A hepatocyte organoid formed by centrifugation in hollow fibers maintained functions for more than 4 months in vitro. We developed a new sinusoid-like structure module having hollow fibers arranged by spacers in a micro-regular arrangement. Inoculated hepatocytes in the extra-fiber space of the module formed the organoid by centrifugation, and they maintained the functions for at least 1 month in vitro. The results indicated that this module seems to be promising as a hybrid artificial liver.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 44 条
[31]  
PATZER JF, 1999, INT J ARTIF ORGANS, V22, P407
[32]   Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system [J].
Pitkin, Z ;
Mullon, C .
ARTIFICIAL ORGANS, 1999, 23 (09) :829-833
[33]  
ROZGA J, 1993, HEPATOLOGY, V17, P258, DOI 10.1016/0270-9139(93)90086-3
[34]  
Sakai Y, 1996, INT J ARTIF ORGANS, V19, P294
[35]  
Stange J, 1999, ARTIF ORGANS, V23, P319
[36]   Cytokines and endotoxin removal by sorbents and its application in push-pull sorbent-based pheresis: The biologic-DTPF system [J].
Steczko, J ;
Ash, SR ;
Blake, DE ;
Carr, DJ ;
Bosley, RH .
ARTIFICIAL ORGANS, 1999, 23 (04) :310-318
[37]   REVERSAL OF FULMINANT HEPATIC-FAILURE USING AN EXTRACORPOREAL LIVER ASSIST DEVICE [J].
SUSSMAN, NL ;
CHONG, MG ;
KOUSSAYER, T ;
HE, DE ;
SHANG, TA ;
WHISENNAND, HH ;
KELLY, JH .
HEPATOLOGY, 1992, 16 (01) :60-65
[38]   THE HEPATIX EXTRACORPOREAL LIVER ASSIST DEVICE - INITIAL CLINICAL-EXPERIENCE [J].
SUSSMAN, NL ;
GISLASON, GT ;
CONLIN, CA ;
KELLY, JH .
ARTIFICIAL ORGANS, 1994, 18 (05) :390-396
[39]   Comparison of different hepatocyte cell lines for use in a hybrid artificial liver model [J].
Takagi, M ;
Fukuda, N ;
Yoshida, T .
CYTOTECHNOLOGY, 1997, 24 (01) :39-45
[40]  
TAKEZAWA T, 1992, J CELL SCI, V101, P495